Cancer clinical trials in the region Grand Est
189 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Phase 3
Colon cancer
Rectal cancer
#NCT06293625
Adenocarcinoma
Locally Advanced
MSS/pMMR
None
Systemic Treatment-Naive
MSI/dMMR
CHRU de Nancy - Hôpitaux de Brabois (Vandœuvre-lès-Nancy), Centre Hospitalier de Colmar (Colmar), Hôpital de Hautepierre - Hôpitaux Universitaires de Strasbourg (Strasbourg), ICANS - Institut de cancérologie Strasbourg Europe (Strasbourg), Institut Godinot (Reims) (and 1 more...)
CHU Dijon
Phase 3
Lung cancer
#NCT06881784
#2024-518154-16-00
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
HRAS
KRAS G12C
KRAS non G12C
NRAS
1
2
Immunotherapy
Chemotherapy
Systemic Treatment-Naive
Centre Hospitalier Universitaire de Strasbourg - Nouvel Hopital Civil (Strasbourg)
Revolution Medicines, Inc.
Phase 3
Lymphoma
#NCT06717347
#2024-515566-13-00
B cell lymphoma
Large B cell lymphoma
None
Treated / Controled
None
Systemic Treatment-Naive
Centre Hospitalier Régional Metz Thionville (C.H.R- Hôpitaux de Thionville) (Thionville)
Merck Sharp & Dohme LLC
Phase 3
Endometrial cancer
#NCT06712472
#2023-503886-44-00
Endometrioid adenocarcinoma
Serous adenocarcinoma
Clear cell carcinoma
Dedifferentiated and undifferentiated endometrial ...
Carcinosarcoma
Stage I
Stage II
Stage III
Localized
Locally Advanced
TP53
None
Surgery
Chemotherapy
Radiotherapy
MSI/dMMR
POLE
Clinique Sainte Anne (Strasbourg)
Gustave Roussy, Campus du cancer, Grand Paris
Phase 3
Liver and bile duct cancer
#NCT05615818
#2023-508100-38-00
Intrahepatic cholangiocarcinoma
Extrahepatic cholangiocarcinoma
Locally Advanced
Metastatic
None
Systemic Treatment-Naive
CHRU de Nancy - Hôpitaux de Brabois (Vandœuvre-lès-Nancy), Institut Godinot (Reims), CHU Reims (Reims)
UNICANCER
Phase 3
Lung cancer
#NCT04613596
#2023-508922-83-00
[KRYSTAL-7] Essai sur l'ADAGRASIB en association chez des patients présentant une mutation KRAS G12C
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
KRAS G12C
PDL1 Positive (>= 50%)
None
Systemic Treatment-Naive
Ghrmsa - Hôpital Emile Muller (Mulhouse)
Mirati Thérapeutique Inc.
Phase 3
Lung cancer
#NCT06097728
#2023-503231-17-00
Mesothelium
Locally Advanced
Metastatic
None
Systemic Treatment-Naive
Centre Hospitalier Universitaire de Strasbourg - Nouvel Hopital Civil (Strasbourg)
AstraZeneca
Phase 3
Lymphoma
#NCT06191744
#2023-506906-38-00
B cell lymphoma
Follicular lymphoma
None
Systemic Treatment-Naive
Clinique Sainte Anne (Strasbourg)
Genmab
Phase 3
Prostate cancer
#NCT03819101
#2023-508072-11-00
Adenocarcinoma
Metastatic Castration-resistant
None
Surgery
Hormone therapy
Institut de Cancérologie de Lorraine - Alexis Vautrin (Vandœuvre-lès-Nancy), Institut Godinot (Reims)
Gustave Roussy, Campus du cancer, Grand Paris
Phase 3
Lung cancer
#NCT05170204
#2023-503920-14-00
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
ALK
None
Systemic Treatment-Naive
EGFR
Immunotherapy
Targeted therapy
Immunotherapy
Targeted therapy
Centre Hospitalier Universitaire de Strasbourg - Nouvel Hopital Civil (Strasbourg)
Hoffmann-La Roche